These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
446 related articles for article (PubMed ID: 24813251)
1. Rescue of Hippo coactivator YAP1 triggers DNA damage-induced apoptosis in hematological cancers. Cottini F; Hideshima T; Xu C; Sattler M; Dori M; Agnelli L; ten Hacken E; Bertilaccio MT; Antonini E; Neri A; Ponzoni M; Marcatti M; Richardson PG; Carrasco R; Kimmelman AC; Wong KK; Caligaris-Cappio F; Blandino G; Kuehl WM; Anderson KC; Tonon G Nat Med; 2014 Jun; 20(6):599-606. PubMed ID: 24813251 [TBL] [Abstract][Full Text] [Related]
2. An alternative DNA damage pathway to apoptosis in hematological cancers. Luk JM; Guan KL Nat Med; 2014 Jun; 20(6):587-8. PubMed ID: 24901566 [No Abstract] [Full Text] [Related]
3. Yap1 phosphorylation by c-Abl is a critical step in selective activation of proapoptotic genes in response to DNA damage. Levy D; Adamovich Y; Reuven N; Shaul Y Mol Cell; 2008 Feb; 29(3):350-61. PubMed ID: 18280240 [TBL] [Abstract][Full Text] [Related]
4. Effects of the hippo signaling pathway in human gastric cancer. Zhou GX; Li XY; Zhang Q; Zhao K; Zhang CP; Xue CH; Yang K; Tian ZB Asian Pac J Cancer Prev; 2013; 14(9):5199-205. PubMed ID: 24175801 [TBL] [Abstract][Full Text] [Related]
5. Mst1 and Mst2 protein kinases restrain intestinal stem cell proliferation and colonic tumorigenesis by inhibition of Yes-associated protein (Yap) overabundance. Zhou D; Zhang Y; Wu H; Barry E; Yin Y; Lawrence E; Dawson D; Willis JE; Markowitz SD; Camargo FD; Avruch J Proc Natl Acad Sci U S A; 2011 Dec; 108(49):E1312-20. PubMed ID: 22042863 [TBL] [Abstract][Full Text] [Related]
6. Assembly and activation of the Hippo signalome by FAT1 tumor suppressor. Martin D; Degese MS; Vitale-Cross L; Iglesias-Bartolome R; Valera JLC; Wang Z; Feng X; Yeerna H; Vadmal V; Moroishi T; Thorne RF; Zaida M; Siegele B; Cheong SC; Molinolo AA; Samuels Y; Tamayo P; Guan KL; Lippman SM; Lyons JG; Gutkind JS Nat Commun; 2018 Jul; 9(1):2372. PubMed ID: 29985391 [TBL] [Abstract][Full Text] [Related]
8. YAP1 acts as oncogenic target of 11q22 amplification in multiple cancer subtypes. Lorenzetto E; Brenca M; Boeri M; Verri C; Piccinin E; Gasparini P; Facchinetti F; Rossi S; Salvatore G; Massimino M; Sozzi G; Maestro R; Modena P Oncotarget; 2014 May; 5(9):2608-21. PubMed ID: 24810989 [TBL] [Abstract][Full Text] [Related]
9. RASAL2 promotes tumor progression through LATS2/YAP1 axis of hippo signaling pathway in colorectal cancer. Pan Y; Tong JHM; Lung RWM; Kang W; Kwan JSH; Chak WP; Tin KY; Chung LY; Wu F; Ng SSM; Mak TWC; Yu J; Lo KW; Chan AWH; To KF Mol Cancer; 2018 Jul; 17(1):102. PubMed ID: 30037330 [TBL] [Abstract][Full Text] [Related]
10. α-catenin is a tumor suppressor that controls cell accumulation by regulating the localization and activity of the transcriptional coactivator Yap1. Silvis MR; Kreger BT; Lien WH; Klezovitch O; Rudakova GM; Camargo FD; Lantz DM; Seykora JT; Vasioukhin V Sci Signal; 2011 May; 4(174):ra33. PubMed ID: 21610251 [TBL] [Abstract][Full Text] [Related]
11. A role for the deubiquitinating enzyme USP28 in control of the DNA-damage response. Zhang D; Zaugg K; Mak TW; Elledge SJ Cell; 2006 Aug; 126(3):529-42. PubMed ID: 16901786 [TBL] [Abstract][Full Text] [Related]
12. LncRNA SNHG15 acts as a ceRNA to regulate YAP1-Hippo signaling pathway by sponging miR-200a-3p in papillary thyroid carcinoma. Wu DM; Wang S; Wen X; Han XR; Wang YJ; Shen M; Fan SH; Zhang ZF; Shan Q; Li MQ; Hu B; Lu J; Chen GQ; Zheng YL Cell Death Dis; 2018 Sep; 9(10):947. PubMed ID: 30237435 [TBL] [Abstract][Full Text] [Related]
13. Yes-associated protein 1 is activated and functions as an oncogene in meningiomas. Baia GS; Caballero OL; Orr BA; Lal A; Ho JS; Cowdrey C; Tihan T; Mawrin C; Riggins GJ Mol Cancer Res; 2012 Jul; 10(7):904-13. PubMed ID: 22618028 [TBL] [Abstract][Full Text] [Related]
14. The Hippo pathway kinase Lats2 prevents DNA damage-induced apoptosis through inhibition of the tyrosine kinase c-Abl. Reuven N; Adler J; Meltser V; Shaul Y Cell Death Differ; 2013 Oct; 20(10):1330-40. PubMed ID: 23852372 [TBL] [Abstract][Full Text] [Related]
15. Overexpression of the YAP1 oncogene in clear cell renal cell carcinoma is associated with poor outcome. Rybarczyk A; Klacz J; Wronska A; Matuszewski M; Kmiec Z; Wierzbicki PM Oncol Rep; 2017 Jul; 38(1):427-439. PubMed ID: 28504812 [TBL] [Abstract][Full Text] [Related]
16. Mst1 and Mst2 maintain hepatocyte quiescence and suppress hepatocellular carcinoma development through inactivation of the Yap1 oncogene. Zhou D; Conrad C; Xia F; Park JS; Payer B; Yin Y; Lauwers GY; Thasler W; Lee JT; Avruch J; Bardeesy N Cancer Cell; 2009 Nov; 16(5):425-38. PubMed ID: 19878874 [TBL] [Abstract][Full Text] [Related]